OWKIN

📍 New York, United States🗓 Founded 2016👥 431 employees💰 Last funded Jul 2020
Owkin is building the first BASI to unlock breakthroughs in therapies, diagnostics, and rejuvenation, while reshaping how humanity understands and engineers biology. Like other frontier AI companies, we believe the leap from narrow tools to true reasoning systems marks the start of a new era — where intelligence is not just assisting scientists but autonomously advancing discovery. Owkin’s moats are structural and compounding. We are creating the only large-scale reasoning model trained natively on patient-level multimodal data and reinforced through real biological feedback — a closed-loop system that continuously improves itself. Exclusive partnerships with world-class hospitals, unique longitudinal datasets, and automated lab infrastructure create a defensibility flywheel similar to the data moats seen in other generational AI companies. By uniting reasoning models, agentic workflows, and living biological systems, Owkin is building the operating system for biology — a platform no one else can replicate, and the inevitable leader in general-purpose biology intelligence.
12
Total investors
8
Early stage
4
Mid stage
0
Late stage
2016
Founded

Investors

12 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United Kingdom
5
France
4
United States
3
Investor activity2016–2020 · investors recorded per year
2016120173201842019120203
Recent (last 2y)Earlier
Frequently asked questions
Who invested in OWKIN?
OWKIN has 12 investors on record on gritt.io, including 8 early-stage backers, 4 mid-stage.
When did OWKIN last raise funding?
The most recent investment in OWKIN recorded on gritt.io was in July 2020.
When was OWKIN founded?
OWKIN was founded in 2016.
What industry is OWKIN in?
OWKIN operates in Technology, Information and Internet. Find similar Technology, Information and Internet investors on gritt.io.
Where is OWKIN based?
OWKIN is headquartered in New York, United States.